CAS: 1578153-27-1

RO6889678

RO6889678 is HBV inhibitor with a complex ADME profile.

(S)-4-(((R)-6-(2-Chloro-4-fluorophenyl)-5-(methoxycarbonyl)-2-(thiazol-2-yl)-3,6-dihydropyrimidin-4-yl)methyl)morpholine-3-carboxylic acid is a selective chemical inhibitor, derived from synthetic organic chemistry methodologies. This compound is engineered for precise interaction with a target protein, modulating cellular pathways involved in disease progression. Its unique structure, including the chlorofluorophenyl and thiazolyl moieties, confers high binding affinity and specificity, making it a valuable tool in biochemical research. The primary use of this compound lies in its ability to elucidate the roles of specific proteins in cellular mechanisms, providing insights into complex biological processes. It's often applied in vitro in biochemical assays and cellular models to investigate pathway modulation, offering potential therapeutic implications. Researchers utilize this specificity to dissect signal transduction pathways, facilitating the development of targeted therapies.